Väliaho Jouni, Faisal Imrul, Ortutay Csaba, Smith C I Edvard, Vihinen Mauno
BioMediTech, University of Tampere, Tampere, Finland.
Present address is HiDucator Ltd., Erämiehentie 2 E 22, Kangasala FI-36200, Finland.
Hum Mutat. 2015 Jun;36(6):638-47. doi: 10.1002/humu.22791. Epub 2015 Apr 27.
Knowledge about features distinguishing deleterious and neutral variations is crucial for interpretation of novel variants. Bruton tyrosine kinase (BTK) contains the highest number of unique disease-causing variations among the human protein kinases, still it is just 10% of all the possible single-nucleotide substitution-caused amino acid variations (SNAVs). In the BTK kinase domain (BTK-KD) can appear altogether 1,495 SNAVs. We investigated them all with bioinformatic and protein structure analysis methods. Most disease-causing variations affect conserved and buried residues disturbing protein stability. Minority of exposed residues is conserved, but strongly tied to pathogenicity. Sixty-seven percent of variations are predicted to be harmful. In 39% of the residues, all the variants are likely harmful, whereas in 10% of sites, all the substitutions are tolerated. Results indicate the importance of the entire kinase domain, involvement in numerous interactions, and intricate functional regulation by conformational change. These results can be extended to other protein kinases and organisms.
了解区分有害变异和中性变异的特征对于解读新变异至关重要。布鲁顿酪氨酸激酶(BTK)在人类蛋白激酶中含有数量最多的独特致病变异,但这仅占所有可能的单核苷酸取代导致的氨基酸变异(SNAV)的10%。在BTK激酶结构域(BTK-KD)中总共可以出现1495种SNAV。我们使用生物信息学和蛋白质结构分析方法对它们进行了全面研究。大多数致病变异影响保守和埋藏残基,扰乱蛋白质稳定性。少数暴露残基是保守的,但与致病性密切相关。67%的变异预计是有害的。在39%的残基中,所有变异可能都是有害的,而在10%的位点,所有取代都是可耐受的。结果表明整个激酶结构域的重要性、参与众多相互作用以及通过构象变化进行复杂的功能调节。这些结果可以推广到其他蛋白激酶和生物体。